Rapid assessment and visualization of normality in high-content and other cell-level data and its impact on the interpretation of experimental results

Journal of Biomolecular Screening

Volumn 19, Issue 5, 2014, Pages 672-684

  Haney, Steven A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Cancer and cancer drugs; Cell based assays; High content screening; Image analysis; Statistical analyses

Indexed keywords

ISOPRENALINE; WORTMANNIN; BETA ARRESTIN; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR;

ANALYTIC METHOD; ARTICLE; BIOMETRY; CALCULATION; CELL ASSAY; CELL FUNCTION; CELL LEVEL; CELL POPULATION; CLINICAL ASSESSMENT; DATA PROCESSING; DOSE RESPONSE; HIGH CONTENT SCREENING; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MEASUREMENT; POPULATION DYNAMICS; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL ANALYSIS; ALGORITHM; CHEMISTRY; COMPUTER LANGUAGE; HIGH THROUGHPUT SCREENING; MCF-7 CELL LINE; METABOLISM; NONPARAMETRIC TEST; NORMAL DISTRIBUTION; PROCEDURES; REPRODUCIBILITY; THEORETICAL MODEL;

ALGORITHMS; BETA-ARRESTINS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GREEN FLUORESCENT PROTEINS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MCF-7 CELLS; MODELS, THEORETICAL; NF-KAPPA B; NORMAL DISTRIBUTION; PHOSPHATIDYLINOSITOL 3-KINASES; PROGRAMMING LANGUAGES; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902160477     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057114526432     Document Type: Article

References (36)

1. Giuliano, K. A.; DeBiasio, R. L.; Dunlay, R. T.; et al. High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery Process. J. Biomol. Screen. 1997, 2, 249
2. Inglese, J. Measuring Biological Responses with Automated Microscopy. In Methods in Enzymology; Academic Press: New York, 2006; pp. 348-363
3. Taylor, D. L.; Haskins, J. R.; Giuliano, K. High Content Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery; Humana Press: New York, 2006
4. Haney, S. A. High Content Screening: Science, Techniques and Applications; John Wiley and Sons: Hoboken, NJ, 2008; p. 391
5. Burchfield, J. G.; Lu, J.; Fazakerley, D. J.; et al. Novel Systems for Dynamically Assessing Insulin Action in Live Cells Reveals Heterogeneity in the Insulin Response. Traffic 2013, 14, 259-273
6. Sisan, D. R.; Halter, M.; Hubbard, J. B; et al. Predicting Rates of Cell State Change Caused by Stochastic Fluctuations Using a Data-Driven Landscape Model. Proc. Natl. Acad. Sci. 2012, 109, 19262-19267
7. LaPan, P.; Zhang, J.; Pan, J.; et al. Single Cell Cytometry of Protein Function in RNAi Treated Cells and in Native Populations. BMC Cell Biol. 2008, 9, e43
8. Slack, M. D.; Martinez, E. D.; Wu, L. F.; et al. Characterizing Heterogeneous Cellular Responses to Perturbations. Proc. Natl. Acad. Sci. 2008, 105, 19306-19311
9. Malo, N.; Hanley, J. A.; Cerquozzi, S.; et al. Statistical Practice in High-Throughput Screening Data Analysis. Nature Biotech. 2006, 24, 167-175
10. Chung, N.; Zhang, X. D.; Kreamer, A.; et al. Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens. J. Biomol. Screen. 2008, 13, 149-158
11. Hastie, T.; Tibshirani, R.; Friedman, J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd ed. Springer-Verlag: New York, 2008; p. 763
12. Hill, A.; Li, Y.; LaPan, P.; et al. Analysis of Multiparametric High-Content Data. In High Content Screening: Science, Techinques and Applications; Haney, S., Ed.; Wiley Interscience: Hoboken, NJ, 2008; pp. 329-353
13. Buchser, W.; Collins, M.; Garyantes, T.; et al. Assay Development Guidelines for Image-Based High Content Screening, High Content Analysis and High Content Imaging. In Assay Guidance Manual; Sittampalam, G. S.; Gal-Edd, N.; Arkin, M.; et al. (Eds.); National Institutes of Health: Bethesda, MD, 2012
14. Bray, M. A.; Carpenter, A. E. Advanced Assay Development Guidelines for Image-Based High Content Screening and Analysis. In Assay Guidance Manual; Sittampalam, G. S.; Gal-Edd, N.; Arkin, M.; et al. (Eds.); National Institutes of Health: Bethesda, MD, 2012
15. Spencer, S. L.; Gaudet, S.; Albeck, J. G.; et al. Non-Genetic Origins of Cell-to-Cell Variability in TRAIL-Induced Apoptosis. Nature 2009, 459, 428-432
16. Barteneva, N. S.; Fasler-Kan, E.; Vorobjev, I. A. Imaging Flow Cytometry: Coping with Heterogeneity in biological systems. J. Histochem. Cytochem. 2012, 60, 723-733
17. Krutzik, P. O.; Irish, J. M.; Nolan, G. P.; et al. Analysis of Protein Phosphorylation and Cellular Signaling Events by Flow Cytometry: Techniques and Clinical Applications. Clin. Immunol. 2004, 110, 206-221
18. Little, S. E.; Popov, S.; Jury, A.; et al. Receptor Tyrosine Kinase Genes Amplified in Glioblastoma Exhibit a Mutual Exclusivity in Variable Proportions Reflective of Individual Tumor Heterogeneity. Cancer Res. 2012, 72, 1614-1620
19. Snuderl, M.; Fazlollahi, L.; Le, L. P.; et al. Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma. Cancer Cell. 2011, 20, 810-817
20. Ljosa, V.; Sokolnicki, K. L.; Carpenter, A. Annotated High- Throughput Microscopy Image Sets for Validation. Nature Meth. 2012, 9, 637
21. Team RDC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, 2012
22. Gross, J.; Ligges, U. nortest: Tests for Normality [Online]; 2012. http://cran.r-project.org/web/packages/nortest/ (accessed Feb 26, 2014)
23. Komsta, L.; Novomestky, F. Moments: Moments, Cumulents, Skewness, Kurtosis and Related Tests [Online]; 2012. http://cran.r-project.org/web/ packages/moments/ (accessed Feb 26, 2014)
24. Ritz, C.; Streibig, J. C. Bioassay Analysis Using R [Online]; 2005. http://ftp.uni-bayreuth.de/math/statlib/R/CRAN/doc/vignettes/drc/drc.pdf (accessed Feb 26, 2014)
25. Wickem, H. ggplot2: Elegant Graphics for Data Analysis. Springer: New York, 2009
26. Baptiste, A. gridExtra: Functions in Grid Graphics [Online]; 2012. http://cran.r-project.org/web/packages/gridExtra/ (accessed Feb 26, 2014)
27. D'Agostino, R. B.; Stephens, M. A. Goodness-of-Fit Techniques. Dekker: New York, 1986; p. 576
28. Han, J.; Kamber, M.; Pei, J. Data Mining: Concepts and Techniques, 3rd ed.; Morgan Kaufmann: Burlington, MA, 2011
29. Zhang, X. D. Illustration of SSMD, Z Score, SSMD*, Z* Score, and t Statistic for Hit Selection in RNAi High- Throughput Screens. J Biomol Screen. 2011, 16, 775-785
30. Lutz, M.; Kenakin, T. Quantitative Molecular Pharmacology and Informatics in Drug Discovery; John Wiley and Sons: Hoboken, NJ, 2000; pp. 428
31. Toriello, N. M. Integrated Microfluidic Bioprocessor for Single-Cell Gene Expression Analysis. Proceedings of the National Academy of Sciences. 2008, 105, 20173-20178
32. Wennekamp, S.; Hiiragi, T. Stochastic Processes in the Development of Pluripotency in Vivo. Biotech J. 2012, 7, 737-744
33. Si-Tayeb, K.; Lemaigre, F. P.; Duncan, S. A. Organogenesis and Development of the Liver. Devel. Cell 2010, 18, 175-189
34. Weber, S.; Fernández-Cachón, M. L.; Nascimento, J. M.; et al. Label-Free Detection of Neuronal Differentiation in Cell Populations Using High-Throughput Live-Cell Imaging of PC12 Cells. PLoS One 2013, 8, e56690
35. Flushberg, D. A.; Roux, J.; Spencer, S. L.; et al. Cells Surviving Fractional Killing by TRAIL Exhibit Transient but Sustainable Resistance and Inflammatory Phenotypes. Mol. Biol. Cell 2013, 24, 2186-2200
36. Niepel, M.; Spencer, S. L.; Sorger, P. K. Non-Genetic Cellto- Cell Variability and the Consequences for Pharmacology. Curr Opin Chem Biol. 2009, 13, 556-561.